Td Private Client Wealth LLC Novo Nordisk A S Transaction History

Td Private Client Wealth LLC

$4.44 Trillion
Q3 2025

A detailed history of Td Private Client Wealth LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Td Private Client Wealth LLC holds 6,720 shares of NVO stock, worth $332,371. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,720

Previous 2,580 160.47%

Holding current value

$332,371

Previous $178 Million 109.39%

% of portfolio

0.01%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 27, 2025	BUY	$45.38 - $71.7 $187,873 - $296,838	4,140 Added 160.47%	6,720 $373 Million
Q2 2025 Jul 15, 2025	SELL	$58.08 - $81.05 $19,224 - $26,827	-331 Reduced 11.37%	2,580 $178 Million
Q1 2025 Apr 29, 2025	SELL	$69.3 - $90.95 $7,137 - $9,367	-103 Reduced 3.42%	2,911 $202 Million
Q4 2024 Feb 11, 2025	SELL	$85.0 - $120.04 $131,240 - $185,341	-1,544 Reduced 33.87%	3,014 $259 Million
Q3 2024 Nov 18, 2024	SELL	$119.07 - $145.42 $42,627 - $52,060	-358 Reduced 7.28%	4,558 $543 Million
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $603,242 - $722,209	4,916 New	4,916 $702 Million
Q1 2024 Aug 16, 2024	SELL	$102.11 - $135.92 $624,402 - $831,150	-6,115 Reduced 46.08%	7,156 $919 Million
Q4 2023 Aug 16, 2024	SELL	$87.78 - $105.45 $266,148 - $319,724	-3,032 Reduced 18.6%	13,271 $1.37 Billion
Q3 2023 Aug 16, 2024	BUY	$90.94 - $199.54 $822,279 - $1.8 Million	9,042 Added 124.53%	16,303 $1.48 Billion
Q2 2023 Aug 16, 2024	BUY	$155.98 - $172.65 $516,449 - $571,644	3,311 Added 83.82%	7,261 $1.18 Billion
Q1 2023 Aug 16, 2024	SELL	$132.34 - $159.14 $127,972 - $153,888	-967 Reduced 19.67%	3,950 $629 Million
Q4 2022 Aug 16, 2024	SELL	$102.55 - $135.33 $14,664 - $19,352	-143 Reduced 2.83%	4,917 $665 Million
Q3 2022 Aug 16, 2024	SELL	$95.28 - $116.93 $5,716 - $7,015	-60 Reduced 1.17%	5,060 $504 Million
Q2 2022 Aug 16, 2024	BUY	$103.24 - $121.81 $250,150 - $295,145	2,423 Added 89.84%	5,120 $571 Million
Q1 2022 Aug 16, 2024	SELL	$93.1 - $112.54 $43,012 - $51,993	-462 Reduced 14.62%	2,697 $300 Million
Q4 2021 Aug 16, 2024	BUY	$95.88 - $117.08 $11,217 - $13,698	117 Added 3.85%	3,159 $354 Million
Q3 2021 Aug 16, 2024	SELL	$84.42 - $106.62 $158,203 - $199,805	-1,874 Reduced 38.12%	3,042 $292 Million
Q2 2021 Aug 16, 2024	SELL	$67.66 - $84.76 $12,923 - $16,189	-191 Reduced 8.71%	2,003 $168 Million
Q1 2021 Aug 16, 2024	SELL	$67.06 - $75.82 $23,471 - $26,536	-350 Reduced 13.76%	2,194 $148 Million
Q4 2020 Aug 16, 2024	SELL	$63.89 - $73.8 $120,815 - $139,555	-1,891 Reduced 42.64%	2,544 $178 Million
Q3 2020 Aug 16, 2024	SELL	$63.69 - $70.22 $47,831 - $52,735	-751 Reduced 14.48%	4,435 $308 Million
Q2 2020 Aug 16, 2024	SELL	$58.54 - $67.94 $182,352 - $211,633	-3,115 Reduced 37.53%	5,186 $340 Million
Q1 2020 Aug 16, 2024	BUY	$49.46 - $64.78 $96,249 - $126,061	1,946 Added 30.62%	8,301 $500 Million
Q4 2019 Aug 16, 2024	BUY	$49.86 - $58.26 $71,748 - $83,836	1,439 Added 29.27%	6,355 $368 Million

Others Institutions Holding NVO

# of Institutions

1,705

Shares Held

294M

Call Options Held

13.7M

Put Options Held

19.7M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $112B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.

Account

Td Private Client Wealth LLC Novo Nordisk A S Transaction History